ArvanitisLAMillerBG. Multiple fixed doses of “seroquel” (quetiapine) inpatients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. Biol Psychiatry1997;42:233–46.
2.
SmallJGHirschSRArvanitisLAMillerBGLinkCGGthe Seroquel Study Group. Quetiapine inpatients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry1997;54:549–57.
3.
PeuskensJLinkCG. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand1997;96:265–73.
4.
AstraZeneca. Seroquel Product Monograph 2001. Compendium of pharmaceuticals and specialities (CPS). 36th ed.Ottawa: Canadian Pharmacists Association; 2001. p 1424.
5.
AndermanBGriffithRW. Clozapine-induced agranulocytosis: A situation report up to August 1976. Eur J Clin Pharmacol1977;11:199–201.
6.
KruppPBarnesP.Clozapine-associated agranulocytosis: Risk and aetiology. Br J Psychiatry1992;160 (Suppl 17):38–40.